课题基金 / 基金详情

BIOELASTIC MATERIAL TO PREVENT POSTLAMINECTOMY ADHESION

BIOELASTIC MATERIAL TO PREVENT POSTLAMINECTOMY ADHESION
防止术后粘连的生物弹性材料
批准号:
2026315
负责人:
JIE XU
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-01 至 1998-02-28

项目摘要

项目成果

JIE XU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This Phase I SBIR proposal to develop bioelastic materials for the prevention of post-laminectomy adhesions is in response to an NICHD, National Center for Rehabilitation Research (NCMRR) solicitation (SBIR 96-2) for "the development of materials that will enhance function and quality of life of individuals with physical disabilities." The physical disability resulting from intervertebral disc herniation constitutes the third most common condition for which worker disability is granted in the U.S. To improve the outcome of intervertebral disc laminectomy would be to improve the quality of life and rehabilitate function for many millions of disabled Americans. The particular bioelastic materials, elastic protein-based polymers comprised of repeating peptide sequences, to be used to exhibit extraordinary biocompatibility; they do not elicit fibrous capsule formation when implanted; they do not support cell attachment nor the adsorption of blood proteins that do, and they can be expected to slowly degrade with breakdown products being natural amino acids. The approach to the prevention of adhesions due to post-intervertebral discectomy involve: the development of two elastic protein-based polymers, their microbial production at high molecular weights and high yields with removal of endotoxins, the sample preparation in terms of elastic sheets and viscoelastic gels, the utilization of the rabbit as the animal model for discectomy at the lumbar spine region using the sheets to cover the midline dural sac and the gel to protect the exiting nerve roots from scarring, and the evaluation of peridural scarring and the presence of inflammatory and pain markers such as interleukin-1 and substance P by means of antibody probes on the histological sections.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Targeting SGLTs for liver disease in a rabbit model of cystic fibrosis
Development of miCas9 mediated gene editing therapies for cystic fibrosis
  • 批准号:
    10811304
  • 项目类别:
  • 资助金额:
    $24.61万
  • 财政年份:
    2022
  • 负责人:
    JIE XU
  • 依托单位:
Development of conditional and inducible gene targeting tools in rabbits
development of immunodeficient rabbit models
  • 批准号:
    9045309
  • 项目类别:
  • 资助金额:
    $18.62万
  • 财政年份:
    2016
  • 负责人:
    JIE XU
  • 依托单位:
海外基金